Skip to main content

Market Overview

35 Stocks Moving in Monday's Pre-Market Session

Share:
35 Stocks Moving in Monday's Pre-Market Session

Gainers

  • Teligent, Inc. (NASDAQ: TLGT) rose 74.4% to $1.10 in pre-market trading after declining over 8% on Friday. A Special Meeting of Stockholders is scheduled to reconvene on Wednesday December 16.
  • Socket Mobile, Inc. (NASDAQ: SCKT) rose 55.6% to $4.14 in pre-market trading as the company Reported in 8K filing that it received notice of forgiveness for a $1.06 million PPP loan.
  • Alexion Pharmaceuticals, Inc. (NASDAQ: ALXN) shares rose 34.7% to $163.00 in pre-market trading after AstraZeneca plc (NASDAQ: AZN) announced plans buy the company for $39 billion.
  • Veru Inc. (NASDAQ: VERU) shares rose 24.3% to $7.90 in pre-market trading after gaining over 6% on Friday.
  • Marathon Patent Group, Inc. (NASDAQ: MARA) shares rose 16.6% to $5.54 in pre-market trading after declining 9% on Friday. Marathon Patent Group last week purchased additional 10K S-19j Pro ASIC miners from Bitmain and announced plans to open a second data center.
  • Riot Blockchain, Inc. (NASDAQ: RIOT) rose 15.3% to $9.99 in pre-market trading after declining 7% on Friday.
  • Torchlight Energy Resources, Inc. (NASDAQ: TRCH) rose 14.8% to $0.8726 in pre-market trading after surging around 20% on Friday.
  • Ideanomics, Inc. (NASDAQ: IDEX) rose 13.6% to $2.09 in pre-market trading.
  • Inseego Corp. (NASDAQ: INSG) rose 10.4% to $15.18 in pre-market trading after climbing 12% on Friday. The company on Thursday announced its 5G MiFi M2000 mobile hotspot is now available at T-Mobile and on Friday announced the availability of 5G MiFi M200 in Japan.
  • Luminar Technologies Inc (NASDAQ: LAZR) rose 9.9% to $30.90 in pre-market trading after declining around 18% on Friday.
  • Collective Growth Corporation (NASDAQ: CGRO) rose 9.5% to $14.24 in pre-market trading. Innoviz Technologies said Friday it will go public via a merger with the SPAC Collective Growth Corporation.
  • Lion Group Holding Ltd. (NASDAQ: LGHL) rose 9.4% to $2.33 in pre-market trading.
  • Phunware, Inc. (NASDAQ: PHUN) rose 8.7% to $0.84 in pre-market trading. Phunware, last week, reported the receipt of privacy shield certification.
  • Gevo, Inc. (NASDAQ: GEVO) rose 8.3% to $1.95 in pre-market trading.
  • Tattooed Chef, Inc. (NASDAQ: TTCF) rose 8% to $19.78 in pre-market trading. Tattooed Chef, last week, reported expansion of its product range with meat alternatives.
  • Amarin Corporation plc (NASDAQ: AMRN) rose 7.8% to $5.40 in pre-market trading after the company said VACEPA Covid-19 Cardiolink-9 randomized trial suggests improvement in outpatient-reported Covid-19 symptoms.
  • Bit Digital, Inc. (NASDAQ: BTBT) rose 7.4% to $6.40 in pre-market trading. Bit Digital, earlier during the month, highlighted completion of acquisition of $13,902,742 worth of bitcoin miners with total hash rate of 1,003.5 Ph/s.
  • Barclays PLC (NYSE: BCS) rose 7.1% to $7.69 in pre-market trading after declining 5% on Friday.
  • Qudian Inc (NYSE: QD) rose 6.1% to $1.41 in pre-market trading after reporting Q3 results.
  • Pluralsight, Inc. (NASDAQ: PS) rose 5.9% to $20.10 in pre-market trading after the company agreed to be acquired by private-equity firm Vista Equity Partners in an all-cash transaction for $20.26 per share..

Find out what's going on in today's market and bring any questions you have to Benzinga's PreMarket Prep.

Check out these big penny stock gainers and losers

Losers

  • Aerpio Pharmaceuticals, Inc. (NASDAQ: ARPO) fell 36.9% to $1.42 in pre-market trading after the company reported statistically significant topline results from razuprotafib glaucoma Phase 2 trial. HC Wainwright & Co. maintained Aerpio Pharmaceuticals with a Neutral and lowered the price target from $2 to $1.5.
  • Destination XL Group, Inc. (NASDAQ: DXLG) fell 36.3% to $0.20 in pre-market trading. Destination XL Group is looking to fiscal year 2021 for continued recovery.
  • Greenwich LifeSciences, Inc. (NASDAQ: GLSI) fell 14.3% to $47.98 in pre-market trading after declining over 22% on Friday. Greenwich LifeSciences last week shared the poster for the GP2 Phase 2b clinical trial final efficacy analysis that was presented Wednesday at the 2020 San Antonio Breast Cancer Symposium.
  • Virgin Galactic Holdings, Inc. (NASDAQ: SPCE) shares fell 13.4% to $27.81 in pre-market trading.
  • SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) fell 10.9% to $7.46 in pre-market trading. SELLAS Life Sciences Group shares tumbled around 53% on Friday after the company reported follow-up data from a randomized Phase 2 VADIS trial of Nelipepimut-S in woman with ductal carcinoma in-situ of the breast.
  • Immutep Limited (NASDAQ: IMMP) fell 7.7% to $3.22 in pre-market trading after declining over 38% on Friday. Immutep last week reported a statistically significant survival benefit for key patient groups in its ongoing Phase IIb AIPAC study in metastatic breast cancer.
  • Vivos Therapeutics, Inc. (NASDAQ: VVOS) shares fell 7.6% to $8.31 in pre-market trading. Vivos Therapeutics shares climbed around 50% on Friday after the company priced its IPO at $6 per share..
  • MDJM Ltd. (NASDAQ: MDJH) fell 7.2% to $3.72 in pre-market trading after gaining around 15% on Friday.
  • Sonoma Pharmaceuticals, Inc. (NASDAQ: SNOA) fell 6.7% to $8.18 in pre-market trading. Sonoma Pharmaceuticals shares climbed over 41% on Friday as the company announced an agreement with Crown Laboratories, a skin care company, for the exclusive rights to sell and market Sonoma's products for the over-the-counter dermatological market in the U.S.
  • NIO Limited (NYSE: NIO) fell 6.3% to $39.34 in pre-market trading after the company priced its 68 million ADS offering at $39 per ADS.
  • ReWalk Robotics Ltd. (NASDAQ: RWLK) fell 6% to $1.27 in pre-market trading.
  • Neos Therapeutics, Inc. (NASDAQ: NEOS) fell 5.7% to $0.6527 in pre-market trading. Neos Therapeutics and Aytu Biosciences last week announced a merger agreement.
  • Xenetic Biosciences, Inc. (NASDAQ: XBIO) fell 5.7% to $2.15 in pre-market trading. Xenetic Biosciences, last week, announced a roughly 2.45 million shares registered direct offering priced at $2.45 per share.
  • AstraZeneca PLC (NYSE: AZN) fell 5.6% to $51.23 in pre-market trading after the company announced it would acquire Alexion Pharmaceuticals for $39 billion in cash and stock.
  • Genetic Technologies Limited (NASDAQ: GENE) fell 4.3% to $3.53 in pre-market trading.
 

Related Articles (ALXN + AMRN)

View Comments and Join the Discussion!

Posted-In: Pre-Market MoversNews Penny Stocks Small Cap Pre-Market Outlook Markets Movers Trading Ideas

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
SPAC
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at vipaccounts@benzinga.com